UUHC Health Feed

Phase 1 Clinical Trials

Huntsman Cancer Institute at the University of Utah stands at the forefront of innovative cancer research and treatment. Phase 1 clinical trials are key to finding better ways to treat cancer safely ...
Nasdaq

Alumis Initiates ONWARD Phase 3 Clinical Program Evaluating ESK-001, an Oral TYK2 Inhibitor, in Moderate-to-Severe Plaque Psoriasis

SOUTH SAN FRANCISCO, Calif., July 29, 2024 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize ...
Seeking Alpha

Akero: Phase 2b NASH Data Bodes Well For Phase 3 SYNCHRONY Program

Akero Therapeutics, Inc. (AKRO) has been able to report positive results from its phase 2b HARMONY study, which used its drug efruxifermin [EFX] for the treatment of patients with pre-cirrhotic MASH ...
Nasdaq

Alumis Inc. Completes Patient Enrollment for Phase 3 ONWARD Clinical Program Evaluating ESK-001 in Moderate-to-Severe Plaque Psoriasis

Alumis Inc. has announced the successful completion of patient enrollment in its pivotal Phase 3 ONWARD clinical program for ESK-001, a treatment for moderate-to-severe plaque psoriasis, involving ...
Seeking Alpha

Athira Pharma, Inc. (ATHA) Discusses Acquisition of Rights to Lasofoxifene Phase III Program for Metastatic Breast Cancer Transcript

Hello, ladies and gentlemen. Thank you for standing by, and welcome to the Athira Pharma conference call. [Operator Instructions] Please be advised that today's conference call may be recorded. I ...
Aviation Week

Etihad Airways announces Phase 4 of global education initiative in India

Etihad Airways recently announced Phase 4 of its "Giving Your Dreams Flight" global education initiative in India. The multi-phased programme is a transformative endeavour by the airline to pave the ...